Relaxin stimulate protein kinase C ζ translocation: Requirement for cyclic adenosine 3′,5′-monophosphate production

Molecular Endocrinology

Volumn 19, Issue 4, 2005, Pages 1012-1023

  Nguyen, Bao T ^a   Dessauer, Carmen W ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CERAMIDE; CHELERYTHRINE; CYCLIC AMP; OLIGODEOXYNUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C ZETA; RELAXIN; SPHINGOMYELIN PHOSPHODIESTERASE; WORTMANNIN; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; MORPHOLINE DERIVATIVE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; ENZYME ACTIVATION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; INHIBITION KINETICS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL MEMBRANE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MONOCYTE; MOUSE; PHYSIOLOGY; PROTEIN TRANSPORT;

MINK CELL FOCUS-FORMING VIRUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL MEMBRANE; CELLS, CULTURED; CHROMONES; CYCLIC AMP; HUMANS; MICE; MONOCYTES; MORPHOLINES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; RELAXIN;

EID: 15444366198     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0279     Document Type: Article

References (69)

1. Sherwood OD 1994 Relaxin. In: Knobil E, Neill JD, eds. The physiology of pregnancy. New York: Raven Press Ltd.; 861-1009
2. Zhao L, Roche PJ, Gunnersen JM, Hammond VE, Tregear GW, Wintour EM, Beck F 1999 Mice without a functional relaxin gene are unable to deliver milk to their pups. Endocrinology 140:445-453
3. Samuel CS, Zhao C, Bathgate RA, Bond CP, Burton MD, Parry LJ, Summers RJ, Tang ML, Amento EP, Tregear GW 2003 Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis. FASEB J 17:121-123
4. Samuel CS, Sakai LY, Amento EP 2001 Relaxin modulates fibrillin-2, but not fibrillin-1, gene expression in human dermal fibroblasts. In: Tragear GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Amsterdam: Kluwer Academic Publishers; 389-392
5. Unemori EN, Amento EP 1990 Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem 265:10681-10685
6. McDonald GA, Sarkar P, Rennke H, Unemori E, Kalluri R, Sukhatme VP 2003 Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo. Am J Physiol 285:F59-F67
7. Unemori EN, Beck LS, Lee WP, Xu Y, Siegel M, Keller G, Liggitt HD, Bauer EA, Amento EP 1993 Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis. J Invest Dermatol 101:280-285
8. Unemori EN, Pickford LB, Salles AL, Piercy CE, Grove BH, Erikson ME, Amento EP 1996 Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest 98:2739-2745
9. Garber SL, Mirochnik Y, Brecklin CS, Unemori EN, Singh AK, Slobodskoy L, Grove BH, Arruda JA, Dunea G 2001 Relaxin decreases renal interstitial fibrosis and slows progression of renal disease. Kidney Int 59:876-882
10. Williams EJ, Benyon RC, Trim N, Hadwin R, Grove BH, Arthur MJ, Unemori EN, Iredale JP 2001 Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo. Gut 49: 577-583
11. Samuel CS, Unemori EN, Mookerjee I, Bathgate RA, Layfield SL, Mak J, Tregear GW, Du XJ 2004 Relaxin modulates cardiac fibroblast proliferation, differentiation and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 145:4125-4133
12. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJ 2002 Activation of orphan receptors by the hormone relaxin. Science 295:671-674
13. Braddon SA 1978 Relaxin-dependent adenosine 6′,5′- monophosphate concentration changes in the mouse pubic symphysis. Endocrinology 102:1292-1299
14. 125I-labeled relaxin and tissue changes in adenosine 3′, 5′-monophosphate levels after in vitro relaxin incubation. Endocrinology 106:1203-1209
15. Sanborn BM, Weisbrodt NW, Kuo HS, Sherwood OD 1980 The interaction of relaxin with the rat uterus. I. Effect of cyclic nucleotide levels and spontaneous contractile activity. Endocrinology 106:1210-1215
16. Hsu CJ, McCormack SM, Sanborn BM 1985 The effect of relaxin on cyclic AMP concentrations in rat myometrial cells in culture. Endocrinology 116:2029-2035
17. Meera P, Anwer K, Monga M, Oberti C, Stefani E, Toro L, Sanborn BM 1995 Relaxin stimulates myometrial calcium-activated potassium channel activity via protein kinase A. Am J Physiol 269:C317
18. Parsell DA, Mak JY, Amento EP, Unemori EN 1996 Relaxin binds to and elicits a response from cells of the human monocytic cell line, THP-1. J Biol Chem 271: 27936-27941
19. Zhang Q, Liu SH, Erikson M, Lewis M, Unemori E 2002 Relaxin activates the MAP kinase pathway in human endometrial stromal cells. J Cell Biochem 85:536-544
20. Bani D, Masini E, Bello MG, Bigazzi M, Sacchi TB 1995 Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 55:5272-5275
21. Bani D, Failli P, Bello MG, Thiemermann C, Bani ST, Bigazzi M, Masini E 1998 Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture. Hypertension 31:1240-1247
22. Nguyen BT, Yang L, Sanborn BM, Dessauer CW 2003 Phosphoinositide 3-kinase activity is required for biphasic stimulation of cyclic adenosine 3′,5′-monophosphate by relaxin. Mol Endocrinol 17:1075-1084
23. Vanhaesebroeck B, Waterfield MD 1999 Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253:239-254
24. Deane JA, Fruman DA 2004 Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 22:563-598
25. Kawabe J, Iwami G, Ebina T, Ohno S, Katada T, Ueda Y, Homcy CJ, Ishikawa Y 1994 Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J Biol Chem 269:16554-16558
26. Kawabe J, Ebina T, Toya Y, Oka N, Schwencke C, Duzic E, Ishikawa Y1996 Regulation of type V adenylyl cyclase by PMA-sensitive and -insensitive protein kinase C isoenzymes in intact cells. FEBS Lett 384:273-276
27. Lin WW, Chang SH, Wang SM 1999 Roles of atypical protein kinase C in lysophosphatidic acid-induced type II adenylyl cyclase activation in RAW 264.7 macrophages. Br J Pharmacol 128:1189-1198
28. Coussens L, Parker PJ, Rhee L, Yang-Feng TL, Chen E, Waterfield MD, Francke U, Ullrich A 1986 Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science 233: 859-866
29. Parker PJ, Coussens L, Totty N, Rhee L, Young S, Chen E, Stabel S, Waterfield MD, Ullrich A1986 The complete primary structure of protein kinase C-the major phorbol ester receptor. Science 233:853-859
30. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, Nishizuka Y 1987 Identification of three additional members of rat protein kinase C family: δ-, ε.- and ζ-subspecies. FEBS Lett 226:125-128
31. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, Nishizuka Y 1989 Protein kinase C ζ subspecies from rat brain: its structure, expression, and properties. Proc Natl Acad Sci USA 86:3099-3103
32. Nakanishi H, Brewer KA, Exton JH 1993 Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 268:13-16
33. Standaert ML, Bandyopadhyay G, Kanon Y, Sajan MP, Farese RV 2001 Insulin and PIP3 activate PKC-ζ by mechanisms that are both dependent and independent of phosphorylation of activation loop (T410) and autophosphorylation (T560) sites. Biochemistry 40:249-255
34. Bani D, Flagiello D, Poupon MF, Nistri S, Poirson-Bichat F, Bigazzi M, Bani ST 1999 Relaxin promotes differentiation of human breast cancer cells MCF-7 transplanted into nude mice. Virchows Arch 435:509-519
35. Dodge KL, Carr DW, Sanborn BM 1999 PKA anchoring to the myometrial plasma membrane is required for cAMP regulation of phosphatidylinositide turnover. Endocrinology 140:5165-5170
36. Dodge K, Sanborn BM 1998 Evidence for inhibition by protein kinase A of receptor/Gq/phospholipase C coupling by a mechanism not involving PLC2. Endocrinology 139:2265-2271
37. Zarreh-Hoshyari-Khah R, Bartsch O, Einspanier A, Pohnke Y, Ivell R 2001 Bioactivity of recombinant prorelaxin from the marmoset monkey. Regul Pept 97: 139-146
38. Bartsch O, Bartlick B, Ivell R 2001 Relaxin signalling links tyrosine phosphorylation to phosphodiesterase and adenylyl cyclase activity. Mol Hum Reprod 7:799-809
39. Renegar RH, Owens III CR 2002 Measurement of plasma and tissue relaxin concentrations in the pregnant hamster and fetus using a homologous radioimmunoassay. Biol Reprod 67:500-505
40. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ 1998 Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281:2042-2045
41. Chou MM, Hou W, Johnson J, Graham LK, Lee MH, Chen CS, Newton AC, Schaffhausen BS, Toker A 1998 Regulation of protein kinase C ζby PI 3-kinase and PDK-1. Curr Biol 8:1069-1077
42. Herrera-Velit P, Knutson KL, Reiner NE 1997 Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-ζ in bacterial lipopolysaccharide-treated human monocytes. J Biol Chem 272:16445-16452
43. Hmama Z, Knutson KL, Herrera-Velit P, Nandan D, Reiner NE 1999 Monocyte adherence induced by lipopolysaccharide involves CD14, LFA-1, and cytohesin-1. Regulation by Rho and phosphatidylinositol 3-kinase. J Biol Chem 274:1050-1057
44. Kalbag SS, Roginsky MS, Jelveh Z, Sulimovici S 1991 Phorbol ester, prolactin, and relaxin cause translocation of protein kinase C from cytosol to membranes in human endometrial cells. Biochim Biophys Acta 1094:85-91
45. Hussain S, Assender JW, Bond M, Wong LF, Murphy D, Newby AC 2002 Activation of protein kinase Cζ is essential for cytokine-induced metalloproteinase-1, -3, and -9 secretion from rabbit smooth muscle cells and inhibits proliferation. J Biol Chem 277:27345-27352
46. Unemori EN, Lewis M, Constant J, Arnold G, Grove BH, Normand J, Deshpande U, Salles A, Pickford LB, Erikson ME, Hunt TK, Huang X 2000 Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites. Wound Repair Regen 8:361-370
47. Sacchi TB, Bani D, Brandi ML, Falchetti A, Bigazzi M 1994 Relaxin influences growth, differentiation and cell-cell adhesion of human breast-cancer cells in culture. Int J Cancer 57:129-134
48. Sanborn BM, Dodge K, Ku CY, Yue C 2001 Relaxin and scaffolding proteins in signalling crosstalk. In: Tragaer GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Amsterdam: Kluwer Academic Publishers; 279-283
49. Palejwala S, Stein DE, Weiss G, Monia BP, Tortoriello D, Goldsmith LT 2001 Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Endocrinology 142:3405-3413
50. Lenhart JA, Ryan PL, Ohleth KM, Palmer SS, Bagnell CA 2001 Relaxin increases secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 during uterine and cervical growth and remodeling in the pig. Endocrinology 142:3941-3949
51. Binder C, Hagemann T, Husen B, Schulz M, Einspanier A 2002 Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases. Mol Hum Reprod 8:789-796
52. Bathgate RA, Samuel CS, Burazin TC, Gundlach AL, Tregear GW 2003 Relaxin: new peptides, receptors and novel actions. Trends Endocrinol Metab 14:207-213
53. Ivell R, Einspanier A 2002 Relaxin peptides are new global players. Trends Endocrinol Metab 13:343-348
54. Neid M, Datta K, Stephan S, Khanna I, Pal S, Shaw L, White M, Mukhopadhyay D 2004 Role of insulin receptor substrates and protein kinase C-ζ in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells. J Biol Chem 279:3941-3948
55. Pal S, Datta K, Khosravi-Far R, Mukhopadhyay D 2001 Role of protein kinase Cζ in Ras-mediated transcriptional activation of vascular permeability factor/vascular endothelial growth factor expression. J Biol Chem 276: 2395-2403
56. Suzuma I, Suzuma K, Ueki K, Hata Y, Feener EP, King GL, Aiello LP 2002 Stretch-induced retinal vascular endothelial growth factor expression is mediated by phosphatidylinositol 3-kinase and protein kinase C (PKC)-ζ but not by stretch-induced ERK1/2, Akt, Ras, or classical/novel PKC pathways. J Biol Chem 277:1047-1057
57. Reisinger K, Kaufmann R, Gille J 2003 Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J Cell Sci 116:225-238
58. Palejwala S, Tseng L, Wojtczuk A, Weiss G, Goldsmith LT 2002 Relaxin gene and protein expression and its regulation of procollagenase and vascular endothelial growth factor in human endometrial cells. Biol Reprod 66: 1743-1748
59. Chapman AB, Zamudio S, Woodmansee W, Merouani A, Osorio F, Johnson A, Moore LG, Dahms T, Coffin C, Abraham WT, Schrier RW 1997 Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol 273: F777-F782
60. Leitges M, Sanz L, Martin P, Duran A, Braun U, Garcia JF, Camacho F, Diaz-Meco MT, Rennert PD, Moscat J 2001 Targeted disruption of the ζPKC gene results in the impairment of the NF-κB pathway. Mol Cell 8:771-780
61. Martin P, Duran A, Minguet S, Gaspar ML, Diaz-Meco MT, Rennert P, Leitges M, Moscat J 2002 Role of ζ PKC in B-cell signaling and function. EMBO J 21:4049-4057
62. Wolf G, Haberstroh U, Neilson EG 1992 Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107
63. Monga M, Ku CY, Dodge K, Sanborn BM 1996 Oxytocin-stimulated responses in a pregnant human immortalized myometrial cell line. Biol Reprod 55:427-432
64. Di Liberto G, Dallot E, Eude-Le Parco I, Cabrol D, Ferre F, Breuiller-Fouche M 2003 A critical role for PKC ζ in endothelin-1-induced uterine contractions at the end of pregnancy. Am J Physiol Cell Physiol 285: C599-C607
65. Goodnight JA, Mischak H, Kolch W, Mushinski JF 1995 Immunocytochemical localization of eight protein kinase C isozymes overexpressed in NIH 3T3 fibroblasts. Isoform-specific association with microfilaments, Golgi, endoplasmic reticulum, and nuclear and cell membranes. J Biol Chem 270:9991-10001
66. Giloh H, Sedat JW 1982 Fluorescence microscopy: reduced photobleaching of rhodamine and fluorescein protein conjugates by n-propyl gallate. Science 217: 1252-1255
67. Knutson KL, Hoenig M 1994 Identification and subcellular characterization of protein kinase-C isoforms in insulinoma β-cells and whole islets. Endocrinology 135: 881-886
68. Gomez J, Garcia A, Borlado L, Bonay P, Martinez A, Silva A, Fresno M, Carrera AC, Eicher-Streiber C, Rebollo A 1997 IL-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3-kinase, and protein kinase C-ζ. J Immunol 158:1516-1522
69. Barbee JL, Deutscher SL, Loomis CR, Burns DJ 1993 The cDNA sequence encoding human protein kinase C-ζ. Gene 132:305-306